Welcome to our dedicated page for LHCG news (Ticker: LHCG), a resource for investors and traders seeking the latest updates and insights on LHCG stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect LHCG's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of LHCG's position in the market.
Optum and LHC Group have announced a strategic acquisition, wherein Optum will acquire LHC Group’s outstanding common stock at $170 per share. The merger aims to enhance value-based care delivery in patients' homes, capitalizing on LHC Group’s reputation for high-quality in-home healthcare and Optum’s extensive resources. The deal is expected to close in the second half of 2022, pending necessary approvals. This acquisition anticipates being neutral to UnitedHealth Group's 2022 net earnings but modestly accretive in 2023.
Archbold Medical Center and LHC Group (NASDAQ: LHCG) announced a joint venture to enhance home health services across seven counties in Georgia. The new partnership, expected to be finalized by May 1, 2022, will expand LHC Group's service area and add two locations in Thomasville and surrounding regions. This initiative is anticipated to generate an incremental annual revenue of approximately $5 million for LHC Group without materially affecting its 2022 earnings per share.
LHC Group (NASDAQ: LHCG) is set to present at two investor conferences this March, aiming to engage with investors and stakeholders in the healthcare sector.
The Oppenheimer 32nd Annual Healthcare Conference will take place on March 16, 2022, at 9:20 a.m. Eastern time, with a live webcast available.
Following that, LHC Group will feature at the Barclays Global Healthcare Conference on March 17, 2022, at 9:30 a.m. Eastern time, also providing a live webcast.
LHC Group (NASDAQ: LHCG) will present at the Cowen 42nd Annual Healthcare Conference on March 8, 2022, at 2:50 p.m. Eastern time. The live webcast can be accessed through the Investor Relations section of their website. Replays will be available for 30 days post-event. LHC Group provides in-home healthcare services across 37 states, focusing on value-based care for patients, particularly the elderly.
LHC Group, Inc. (NASDAQ: LHCG) reported a 9.6% increase in net service revenue for Q4 2021, totaling $583.4 million. Net income for the quarter was $15.7 million ($0.50 per diluted share), with adjusted net income at $39.4 million ($1.26 per diluted share). Full-year revenue reached $2.220 billion, up 7.6%, with net income of $115.7 million ($3.69 per diluted share).
The company expects 2022 revenue between $2.500 billion and $2.550 billion, with adjusted earnings per diluted share projected at $5.60 to $6.00.
LHC Group, Inc. (NASDAQ: LHCG) will release its fourth quarter and full year 2021 results after market close on February 23, 2022. A conference call to discuss the earnings will take place on February 24, 2022, at 9:00 a.m. Eastern time. Interested participants can join by calling (877) 407-9208. A live webcast of the call will be available on www.LHCGroup.com. LHC Group provides in-home healthcare services across 37 states, servicing 60% of the U.S. population aged 65 and older, with a focus on value-based healthcare.
LHC Group (NASDAQ: LHCG) is set to present at the 40th Annual J.P. Morgan Healthcare Conference from January 10-13, 2022. The Company will participate virtually on January 12 at 1:30 p.m. Eastern time. Investors can access the live webcast through the Investor Relations section of the Company's website. Replays will be available for 30 days following the event.
LHC Group has approved a share repurchase program worth $250 million, reflecting the Board's confidence in the company's financial stability. This initiative aims to enhance shareholder value and will be funded through current cash, future operational cash flow, and borrowings. The program allows for various purchase methods, with no set completion date, subject to market conditions and legal compliance. LHC Group emphasizes its commitment to both repurchasing shares and investing in growth opportunities.
LHC Group (NASDAQ: LHCG) will hold fireside chats at two investor conferences in December 2021. The first chat takes place on December 3 at 12:00 p.m. Eastern time during the Stephens Annual Investment Conference, followed by a webcast. The second event is scheduled for December 6 at 12:20 p.m. Eastern time at the BofA Securities Home Care Conference, also featuring a live webcast. Interested participants can find detailed information and register through the Investor Relations section of the company's website.
LHC Group (NASDAQ: LHCG) reported a 6.6% increase in net service revenue, reaching $565.5 million for Q3 2021. Net income rose to $27.7 million ($0.88 per diluted share), while adjusted net income was $45.7 million ($1.45 per diluted share). The firm anticipates 2021 revenue of $2.215-$2.220 billion, up from previous guidance. M&A activity has brought in $300 million in annualized revenue, expected to contribute $20-$25 million in EBITDA in 2022. Home health admissions grew by 3.6%, and the company continues to lead in quality and patient satisfaction.
FAQ
What is the market cap of LHCG (LHCG)?
